SCHEMBL6563934

SCHEMBL6563934

Cc1cc(CCCNc2ccccc2)ccc1C(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.49
BCL2L1 Q07817 1/20 0.48
MCL1 Q07820 1/20 0.48
HDAC1 Q13547 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
TRPV1 Q8NER1 1/20 0.42
HPGD P15428 1/20 0.42
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
SCN9A Q15858 1/20 0.40
LMNA P02545 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GCGR P47871 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7674335 0.90 PRSS1 (0.49) SRD5A2BCL2L1MCL1HDAC1HDAC8
SCHEMBL11220023 0.82 SRD5A2 (0.54) SRD5A2TRPV1HPGDALDH1A1
SCHEMBL28377134 0.79 SRD5A2 (0.57) SRD5A2HPGDKDM4ELMNAKMT2A
SCHEMBL9150733 0.77 SIGMAR1 (0.51) SRD5A2HDAC1NPC1KDM4EKMT2A
SCHEMBL11231215 0.76 SRD5A2 (0.59) SRD5A2SMN1; SMN2HPGDKDM4EKMT2A
SCHEMBL28214103 0.76 ALDH1A1 (0.48) SRD5A2HDAC1HDAC8HDAC6NPC1
SCHEMBL10413178 0.74 CYP4A11 (0.60) NPC1RAB9ASMN1; SMN2TRPV1HPGD
SCHEMBL27745360 0.72 SRD5A2 (0.56) SRD5A2HPGDKDM4ELMNAKMT2A
SCHEMBL10411587 0.72 TRPV1 (0.48) HDAC1HDAC8HDAC6NPC1RAB9A
SCHEMBL6563737 0.72 EGLN1 (0.45) SRD5A2RAB9AHPGDKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140802-B1 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-03-17 EP disclosed